Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) EPS (Basic): ¥0.17 (TTM As of Mar. 2026)


BJSE:920367 Jiangxi Xinganjiang Pharmaceutical Co Ltd BJSE:920367
63 GF Score
Price ¥18.10
GF Value ¥12.19
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Jiangxi Xinganjiang Pharmaceutical Co EPS (Basic)?

Jiangxi Xinganjiang Pharmaceutical Co BJSE:920367 63 EPS (Basic) is ¥0.17 as of Mar. 2026. GuruFocus rates BJSE:920367 with a GF Score™ of 63/100 and a GF Value™ of ¥12.19 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Jiangxi Xinganjiang Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ¥0.04. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.17.

Jiangxi Xinganjiang Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2026 was ¥0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.17.

Jiangxi Xinganjiang Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2026 was ¥0.04. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.18.

During the past 12 months, Jiangxi Xinganjiang Pharmaceutical Co's average EPS without NRIGrowth Rate was -28.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was -36.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was -26.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Jiangxi Xinganjiang Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 18.80% per year. The lowest was -39.60% per year. And the median was -21.20% per year.

Jiangxi Xinganjiang Pharmaceutical Co  (BJSE:920367) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Jiangxi Xinganjiang Pharmaceutical Co EPS (Basic) Related Terms

Jiangxi Xinganjiang Pharmaceutical Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Jiangxi Xinganjiang Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangxi Xinganjiang Pharmaceutical Co EPS (Basic) Chart

Jiangxi Xinganjiang Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.08 0.90 0.68 0.32 0.21

Jiangxi Xinganjiang Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.01 0.03 0.09 0.04
BJSE:920367
63GF Score
Jiangxi Xinganjiang Pharmaceutical Co Ltd BJSE:920367
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangxi Xinganjiang Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Jiangxi Xinganjiang Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(14.594-0)/69.497
=0.21

Jiangxi Xinganjiang Pharmaceutical Co's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(3.108-0)/77.698
=0.04

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ¥0.17 mean?
Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) has a EPS (Basic) of ¥0.17 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Jiangxi Xinganjiang Pharmaceutical Co and its competitors.
Is Jiangxi Xinganjiang Pharmaceutical Co's EPS (Basic) too high?
Jiangxi Xinganjiang Pharmaceutical Co's current EPS (Basic) is ¥0.17. Overall, Jiangxi Xinganjiang Pharmaceutical Co has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jiangxi Xinganjiang Pharmaceutical Co's EPS (Basic) compare to ZTS?
Jiangxi Xinganjiang Pharmaceutical Co's EPS (Basic) of ¥0.17 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Jiangxi Xinganjiang Pharmaceutical Co and its competitors. Jiangxi Xinganjiang Pharmaceutical Co's current EPS (Basic) is ¥0.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangxi Xinganjiang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥12.19, compared to a current price of ¥18.10 — trading 48.5% above its estimated fair value. The current EPS (Basic) is ¥0.17. Jiangxi Xinganjiang Pharmaceutical Co's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367), the current EPS (Basic) is ¥0.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥18.10 is trading 48.5% above its estimated GF Value™ of ¥12.19. GuruFocus considers Jiangxi Xinganjiang Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for BJSE:920367:

  • EPS (Basic): ¥0.17
  • GF Value™: ¥12.19 vs. price of ¥18.10 (48.5% above fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the BJSE:920367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jiangxi Xinganjiang Pharmaceutical Co Business Description

Address No. 36 Yunzhang Road, Industrial Park, Jizhou District, Jiangxi Province, Ji'an City, CHN, 343000
Jiangxi Xinganjiang Pharmaceutical Co Ltd conducts research and development, production, and sales of chemical raw materials, chemical preparations, and Chinese patent medicines. The company's raw material medicine products are mainly calcium gluconate, zinc gluconate, ferrous gluconate, and other gluconate series raw material medicines. Its main chemical preparations are vitamin C chewable tablets and compound Yinqiao aminomin capsules, and Phenaminokamin Tablets.
63GF Score

Get the complete analysis for BJSE:920367

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.10
Price
¥12.19
GF Value